| Â | Non-drug users | Non-injection drug users | Injection drug users | Â |
|---|
Characteristic
|
HIV-1(−), n = 194
|
HIV-1(−), n = 48
|
HIV-1(+), n = 139
|
HIV-1(−), n = 214
|
HIV-1(+), n = 157
|
P
|
|---|
Females, n (%) | 114 (58.8) | 19 (39.6) | 84 (60.4) | 14 (6.5) | 86 (54.8) | <0.0001 |
Age, yrs. | 30.8 (12.8) | 30.4 (11.8) | 36.0 (14.5)a,b | 31.7 (9.1) | 30.6 (6.5) | <0.0001 |
CD4+ T cells/μL | 831 (513) | 809 (486) | 553 (479)a,b,c | 905 (641) | 456 (449)a,b,c | <0.0001 |
- Data shown are number (n) and proportions (%) of subjects for gender and medians (IQR, interquartile range) for age and CD4+ T cell counts. Statistical comparison of proportions among groups was conducted by Chi-Square test. Age and CD4+ T cell comparisons across groups were performed using Kruskal Wallis test followed by Dunn’s post-hoc test for multiple comparisons. HIV-1(+), human immunodeficiency virus-1 infected, HIV-1(−) uninfected. aP < 0.001 vs. non-drug users; bP < 0.001 vs. HIV-1(−) non-injection drug users; and cP < 0.001 vs. HIV-1(−) injection drug users
